Recent Studies Support Diversified Vaccine Strategies, Aligning with GeoVax's MVA-Based GEO-CM04S1 for Enhanced Protection, ...

Recent Studies Support Diversified Vaccine Strategies, Aligning with GeoVax's MVA-Based GEO-CM04S1 for Enhanced Protection, Particularly for Immunocompromised Populations ATLANTA, GA - February 24 ...

GeoVax Labs' Mpox vaccine still has a long way to go before gaining approval or generating any type of revenue. Its treatment is still in pre-clinical development. That phase of development alone ...

Ethical Vaccine Development & Public Confidence – GeoVax embraces open regulatory processes, rigorous safety standards, and public access to data, ensuring confidence in its vaccines. These principles ...

Mpox, Oncology Therapies and AI Integration Positions GeoVax for Strong Momentum. ATLANTA, GA - February 5, 2025 (NEWMEDIAWIRE) - GeoVax Labs, ...

This versatility allows GeoVax to develop vaccines targeting multiple aspects of a single pathogen or several pathogens simultaneously. Originally developed as a safer smallpox vaccine ...

Geovax Labs (NASDAQ:GOVX) just reported results for the second quarter of 2024. Geovax Labs reported earnings per share of -$1.99. This was above the analyst estimate for EPS of -$4.43.

GeoVax Labs has a 52-week low of $1.09 and a 52-week high of $11.18. The company’s fifty day moving average price is $2.08 and its two-hundred day moving average price is $2.66. About GeoVax Labs ...

As the industry moves towards a more integrated and diversified vaccine ecosystem, GeoVax’s MVA-based vaccines should provide a scalable, durable, and globally accessible solution that enhances the ...

GeoVax Labs, Inc. is a clinical-stage biotechnology company, which engages in the development of human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...